See also this year's filing and all EDGAR filings for this company.
PDF Report 0000707511_2017_REGENERX_BIOPHARMACEUTICALS_INC.pdf
Logs
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'PROVECTUS BIOPHARMACEUTICALS INC.', 'shared_tokens': {'biopharmaceuticals'}}]} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000707511')"} |
Graph
Absolute values for 0000707511, REGENERX BIOPHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 849,431 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 7,219 |
| 3 | remainder_Assets | 5,752 |
| 4 | LiabilitiesCurrent | 659,756 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 6,269,204 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,529,983 |
| 9 | ResearchAndDevelopmentExpense | 237,344 |
| 10 | remainder_Expenses | 173,355 |
| 11 | remainder_Revenues | 93,308 |
| 12 | remainder_NetIncome | 2,076,499 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 862,402 |
| 1 | Liabilities | 6,928,960 |
| 2 | Expenses | 1,940,682 |
| 3 | Revenues | 93,308 |
| 4 | StockholdersEquity | -6,066,558 |
| 5 | NetIncome | 229,125 |
| 6 | ComprehensiveNetIncome | 229,125 |
| 7 | BaseVar | 5,950,926 |
| 8 | EconomicCapitalRatio | -2.62 |
Edgar->Model Mapping
Feature Distribution
